FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Atopic Dermatitis
Reports on atopic dermatitis findings from University of Agriculture provide new insights
March 15th, 2007
New investigation results, "Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice," are detailed in a study published in Clinical & Experimental Allergy. According to a study from Tokyo, Japan, "Continuous oral administration of live Lactobacillus rhamnosus GG (L. GG) to pregnant subjects with atopic dermatitis and their children, suppressed the frequency of atopic dermatitis." "The details of mechanisms and immune systems involved in this suppressive effect, however, remain speculative. We sought to clarify suppressive mechanisms of L. GG on atopic dermatitis by using NC/Nga mice, a model of human atopic...
Source: FDA Law Weekly (2007-03-15)
|
